Skip to content
JOIN 7INVESTING TODAY – YOUR PORTFOLIO WILL THANK YOU!
LOGIN
Toggle Navigation
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
MENU
My Account
Advisor Updates
View All
Best Buys
Community Ideas
Strong Buys
Subscriber Calls
Watchlist
Company Updates
View All
Deep Dives
Recommendations
Articles
Portfolios
LOGIN
SUBSCRIBE TODAY
Search for:
FILTER CONTENT
Filters
Filters
After
Before
Retail
(
36
)
Enterprise Software
(
82
)
Consumer Discretionary
(
22
)
Internet Infrastructure
(
3
)
Semiconductors
(
20
)
Industrial
(
7
)
Pharmaceuticals
(
1
)
Biotechnology
(
35
)
Telecommunications
(
3
)
Energy
(
9
)
Financial Services
(
47
)
Consumer Electronics
(
3
)
Entertainment
(
7
)
Health Care Technology
(
52
)
Insurance
(
8
)
Travel
(
4
)
Space Economy
(
8
)
Cannabis
(
1
)
Defense & Security
(
1
)
Advertising
(
19
)
×
Show
(
139
)
Cancel
Research
By
Maxx Chatsko
Published On: May 12, 2022
NeuBase Therapeutics Tries to Thread a Needle
READ MORE
By
Maxx Chatsko
Published On: May 12, 2022
Avita Medical Hums Along, Awaiting Data Readouts
READ MORE
By
Maxx Chatsko
Published On: May 1, 2022
May 2022 Stock Rec #5
READ MORE
By
Maxx Chatsko
Published On: April 21, 2022
The Colon Cancer Screening Gauntlet Has Been Thrown
READ MORE
By
Maxx Chatsko
Published On: April 15, 2022
April 2022 Best Buy #2
READ MORE
By
Maxx Chatsko
Published On: April 1, 2022
April 2022 Stock Rec #6
READ MORE
By
Maxx Chatsko
Published On: March 7, 2022
Toripalimab is Not the Biggest Source of Uncertainty for Coherus BioSciences
READ MORE
By
Maxx Chatsko
Published On: March 1, 2022
March 2022 Stock Rec #2
READ MORE
By
Maxx Chatsko
Published On: February 8, 2022
Will Solid-State Batteries Live Up to the Hype?
READ MORE
By
Maxx Chatsko
Published On: February 1, 2022
February 2022 Stock Rec #5
READ MORE
By
Maxx Chatsko
Published On: January 26, 2022
“Very High Risk” Isn’t Very Helpful
READ MORE
By
Maxx Chatsko
Published On: January 19, 2022
Coherus BioSciences: Circle Your Calendars for February 10
READ MORE
By
Maxx Chatsko
Published On: January 14, 2022
Should You Invest in Synthetic Biology Stocks?
READ MORE
By
Maxx Chatsko
Published On: January 7, 2022
Avita Medical is Way Ahead of (My) Schedule
READ MORE
By
Maxx Chatsko
Published On: January 6, 2022
Cystic Fibrosis Foundation Invests Up to $5 Million in BiomX
READ MORE
By
Maxx Chatsko
Published On: January 1, 2022
January 2022 Stock Rec #2
READ MORE
1
2
Next
Load More Company Updates
Page load link
Go to Top
